Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

Clinical Infectious Diseases

Volumn 57, Issue 1, 2013, Pages 112-121

  Rotger, Margalida ^a   Glass, Tracy R ^b   Junier, Thomas ^c,d   Lundgren, Jens ^e,f   Neaton, James D ^e,g   Poloni, Estella S ^k   Van 'T Wout, Angélique B ^h   Lubomirov, Rubin ^a   Colombo, Sara ^a   Martinez, Raquel ^a   Rauch, Andri ^i,m   Günthard, Huldrych F ^i,l   Neuhaus, Jacqueline ^e,g   Wentworth, Deborah ^e,g   Van Manen, Danielle ^h   Gras, Luuk A ^h   Schuitemaker, Hanneke ^h   Albini, Laura ⁿ   Torti, Carlo ^n,o   Jacobson, Lisa P ^p   Li, Xiuhong ^p   Kingsley, Lawrence A ^p   Carli, Federica ^q   Guaraldi, Giovanni ^q   Ford, Emily S ^r   Sereti, Irini ^r   Hadigan, Colleen ^r   Martinez, Esteban ^s   Arnedo, Mireia ^s   Egaña Gorroño, Lander ^s   Gatell, Jose M ^s   Law, Matthew ^t   Bendall, Courtney ^t   Petoumenos, Kathy ^t   Rockstroh, Jürgen ^u   Wasmuth, Jan Christian ^u   Kabamba, Kabeya ^v   Delforge, Marc ^v   De Wit, Stephane ^v   Berger, Florian ^w   Mauss, Stefan ^w   De Paz Sierra, Mariana ^x   Losso, Marcelo ^x   Belloso, Waldo H ^x   Leyes, Maria ^y   Campins, Antoni ^y   Mondi, Annalisa ^z   De Luca, Andrea ^z,ab   Bernardino, Ignacio ^aa   Barriuso Iglesias, Mónica ^aa   Torrecilla Rodriguez, Ana ^aa   Gonzalez Garcia, Juan ^aa   Arribas, José R ^aa   Fanti, Iuri ^ab   Gel, Silvia ^ac   Puig, Jordi ^ac   Negredo, Eugenia ^ac   Gutierrez, Mar ^ad   Domingo, Pere ^ad   Fischer, Julia ^ae   Fätkenheuer, Gerd ^ae   Alonso Villaverde, Carlos ^af   MacKen, Alan ^ag   Woo, James ^ah   McGinty, Tara ^ai   Mallon, Patrick ^ag   Mangili, Alexandra ^aj   Skinner, Sally ^aj   Wanke, Christine A ^aj   Reiss, Peter ^h   Weber, Rainer ^i,l   Bucher, Heiner C ^b,i   Fellay, Jacques ^a,d,i   Telenti, Amalio ^a,i   Tarr, Philip E ^i,j   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d EPFL   (Switzerland)

^e International Network for Strategic Initiatives in Global HIV Trials   (Switzerland)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF MINNESOTA   (United States)

^h National AIDS Therapy Evaluation Center   (Netherlands)

ⁱ Swiss HIV Cohort Study ^*  (Switzerland)

^j UNIVERSITY OF BASEL   (Switzerland)

^k UNIVERSITY OF GENEVA   (Switzerland)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ UNIVERSITY OF BRESCIA   (Italy)

^o UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^p Multicenter AIDS Cohort Study   (Italy)

^q UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^r NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^s INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^t UNIVERSITY OF NEW SOUTH WALES   (Australia)

^u UNIVERSITY HOSPITAL BONN   (Germany)

^v SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^w Ctr HIV and Hepatogastroenterology   (Germany)

^x Cohorte LATINA ^*  (Argentina)

^y HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^z CATHOLIC UNIVERSITY   (Italy)

^aa HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^ab Italian Cohort Naive for Antiretrovirals Foundation   (Italy)

^ac HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^ad HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^ae UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^af Hospital Sant Pau i Santa Tecla   (Spain)

^ag UNIVERSITY COLLEGE DUBLIN   (Ireland)

^ah ST JAMES S HOSPITAL   (Ireland)

^ai MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^aj TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

antiretroviral therapy; coronary artery disease; genetics; HIV infection; traditional risk factors

Indexed keywords

ABACAVIR; LOPINAVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIRETROVIRAL THERAPY; CORONARY ARTERY DISEASE; GENETICS; HIV INFECTION; TRADITIONAL RISK FACTORS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 84878859337     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit196     Document Type: Article

References (39)

1. d'Arminio A, Sabin CA, Phillips AN, et al. Cardio-and cerebrovascular events in HIV-infected persons. AIDS (London) 2004; 18:1811-7.
2. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-35. (Pubitemid 46658704)
3. Grinspoon SK, Grunfeld C, Kotler DP, et al. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation 2008; 118:198-210.
4. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007; 44:1625-31. (Pubitemid 46871511)
5. Periard D, Cavassini M, Taffe P, et al. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 2008; 46: 761-7. (Pubitemid 351321563)
6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-12. (Pubitemid 47037350)
7. Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS 2010; 24:1509-17.
8. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
9. Strategies for Management of Antiretroviral Therapy Study GEl-Sadr WMLundgren JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-96. (Pubitemid 44837777)
10. Sabin CA, Worm SW, Weber R, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008; 371:1417-26.
11. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003; 289:2978-82. (Pubitemid 37430100)
12. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001; 104:257-62. (Pubitemid 32666944)
13. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr., et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middleaged adults: a prospective study of parents and offspring. JAMA 2004; 291:2204-11. (Pubitemid 38608169)
14. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2005; 294:3117-23. (Pubitemid 43016803)
15. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361:2518-28.
16. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43:333-8.
17. Essebag V, Genest J Jr., Suissa S, Pilote L. The nested case-control study in cardiology. Am Heart J 2003; 146:581-90. (Pubitemid 37281701)
18. World Health Organization. MONICA Manual, Part IV: Event Registration. Section 1: Coronary Event Registration Data Component. 1999. Available at: www.ktl.fi/publications/monica/manual/part4/iv-1.htm. Accessed 17 December 2012.
19. Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 2009; 38:263-73.
20. Voight BF, Kang HM, Ding J, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012; 8:e1002793.
21. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006; 38:904-9. (Pubitemid 44141658)
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
23. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-7.
24. Rotger M, Gsponer T, Martinez R, et al. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51: 1090-8.
25. Friis-Moller N, Thiebaut R, Reiss P, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 2010; 17:491-501.
26. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011; 30:377-99.
27. Clayton D, Hills M. Statistical models in epidemiology. New York, NY: Oxford University Press, 1993.
28. Ortiz M, Poloni ES, Furrer H, et al. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011; 203:620-4.
29. Berg AO, Baird MA, Botkin JR, et al. National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. Ann Intern Med 2009; 151:872-7.
30. Chow CK, Islam S, Bautista L, et al. Parental history and myocardial infarction risk across the world: the INTERHEART Study. J Am Coll Cardiol 2011; 57:619-27.
31. Ripatti S, Tikkanen E, Orho-Melander M, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010; 376:1393-400.
32. Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis 2012; 205(suppl 3):S355-61.
33. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIVinfected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999; 100:700-5. (Pubitemid 29383638)
34. Sabin C, Worm SW, Law M, et al., on behalf of the D:A:D study group. Association between markers of immunosuppression and the risk of cardiovascular disease (CVD): the D:A:D study. In: 19th Conference on Retroviruses and Opportunistic Infections, Seattle,WA, 2012. Poster 822.
35. Klein DL, Leyden WA, Xu L, et al. Contribution of immunodeficiency to CHD: cohort study of HIV+ and HIV-Kaiser Permanente members. In: 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011. Poster 810.
36. Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis 2012; 55:600-7.
37. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-9.
38. Thanassoulis G, Vasan RS. Genetic cardiovascular risk prediction: will we get there? Circulation 2010; 122:2323-34.
39. Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7:e44454. HIV